Nurr1 Antibodies

Santa Cruz Biotechnology features a diverse variety of Nurr1 monoclonal antibodies for advanced research in neuroscience and developmental biology. Nurr1 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nurr1, also known as NR4A2, is a nuclear receptor with a vital role in the development and maintenance of dopaminergic neurons. The nuclear receptor regulates gene expression involved in neuronal survival and differentiation, making it significant in neurodegenerative diseases such as Parkinson's disease. Understanding Nurr1 function is essential for developing therapeutic strategies aimed at neuroprotection and neuroregeneration. Researchers worldwide utilize Nurr1 monoclonal antibodies to investigate molecular pathways in neuronal development. Advanced research techniques with Nurr1 monoclonal antibodies enable detailed analysis of cellular mechanisms and potential therapeutic targets. Current studies focusing on Nurr1 continue to reveal new insights into neurodegenerative disorders. Santa Cruz Biotechnology monoclonal antibodies for Nurr1 support researchers in advancing scientific understanding of neurological conditions and potential treatments.